GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) was the target of a large growth in short interest in September. As of September 30th, there was short interest totaling 3,840 shares, a growth of 693.4% from the September 15th total of 484 shares. Based on an average daily trading volume, of 10,458 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.1% of the shares of the company are short sold.
Hedge Funds Weigh In On GMO U.S. Value ETF
Several large investors have recently bought and sold shares of GMOV. Fifth Third Bancorp bought a new stake in shares of GMO U.S. Value ETF during the 1st quarter worth about $84,000. Pathway Financial Advisors LLC acquired a new position in shares of GMO U.S. Value ETF during the second quarter valued at approximately $246,000. Kestra Private Wealth Services LLC acquired a new position in shares of GMO U.S. Value ETF during the first quarter valued at approximately $333,000. Finally, Essential Partners LLC increased its stake in shares of GMO U.S. Value ETF by 8.6% during the first quarter. Essential Partners LLC now owns 60,238 shares of the company’s stock valued at $1,692,000 after acquiring an additional 4,774 shares during the period.
GMO U.S. Value ETF Price Performance
Shares of GMO U.S. Value ETF stock opened at $31.95 on Friday. GMO U.S. Value ETF has a 1-year low of $25.66 and a 1-year high of $33.47. The business’s fifty day moving average price is $32.39 and its two-hundred day moving average price is $30.70. The company has a market capitalization of $95.85 million, a P/E ratio of 12.08 and a beta of 0.65.
GMO U.S. Value ETF Increases Dividend
About GMO U.S. Value ETF
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
See Also
- Five stocks we like better than GMO U.S. Value ETF
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
